LHX March 27th Options Begin Trading

L3Harris (LHX) is presented with two option strategies: selling the $345 put (bid $12.00) would set an effective purchase basis of $333.00 versus the spot $346.90 and carries a 56% probability of expiring worthless, producing a 3.48% return (25.41% annualized) on cash committed. Alternatively, a covered call at the $350 strike (bid $11.90) against shares bought at $346.90 would cap upside at $350 but generate a 4.32% total return if called by the March 27 expiration and has a 50% chance of expiring worthless, yielding a 3.43% premium boost (25.06% annualized). Implied volatilities are ~30% (put) and 29% (call) versus a trailing-12-month realized volatility of 23%, and the piece frames these as trade ideas rather than company fundamental news.

Analysis

Market structure: Short-dated income demand is creating pick-up in OTM premium for LHX; $345 put bid $12 and $350 call bid $11.90 imply market participants are willing to pay ~3.4%+ monthly yield (25%+ annualized) for one-month credit exposure into Mar 27. Implied vols (29–30%) exceed trailing realized vol (23%) by ~6–7ppt, signaling consistent premium available to sellers but also latent demand for downside protection.

Risk assessment: Primary tail is a short-dated gap from a defense-contract shock or macro risk that lifts realized vol from 23% to 35–45%—a 10–20ppt jump that can wipe option sellers in days. Immediate (days) risk: assignment and fast delta moves; short-term (weeks) risk: IV re-pricing around news or budget hearings; long-term: secular defense budget cuts or program losses that depress multiple-year earnings. Hidden dependency: options flows can create feedback loops (delta-hedge selling into weakness), amplifying moves.

Trade implications: Direct play is cash-secured put sell at $345 (net cost basis $333) and covered-call sell at $350 for holders; both are income-heavy, short-dated plays best sized as tactical overlays (1–5% total portfolio each). If choosing to sell premium, use strict risk controls: cap exposure, buy tail protection (LHX $320 put or 5% OTM SPX put) and avoid net short-gamma positions >5% NAV. Cross-asset: stronger option selling pressure can modestly increase equity skew and press risk premia into fixed income via safe-haven flows.

Contrarian angle: Consensus income trade misses concentration risk — implied>realized vol suggests selling edge, but with only ~50–56% odds of expiry worthless, downside assignment is material; mispricing exists only if you size and hedge. Historical parallels: defense names have shown outsized one-day gaps on contract outcomes; a conservative roll/hedge regime outperforms naive yield-chasing sellers over 12 months.

Key Decisions for Investors

• Establish a cash-secured short put on LHX: sell 1–2% portfolio notional of Mar‑27 $345 puts (collect ~$12) targeting effective cost basis $333; set hard stop/roll if LHX trades below $320 or if IV >40% (exit or roll down to protect capital).
• Buy-and-write tactical position: deploy 2–3% portfolio to buy LHX and sell Mar‑27 $350 calls (collect ~$11.90) aiming for 4.32% return to expiry; buy back the call if LHX > $360 or if IV falls <20% and the cost to close exceeds 50% of premium collected.
• Limit net short-gamma exposure: cap combined premium-selling exposure in LHX at 5% of NAV. Hedge tail risk by allocating 0.5–1% NAV to LHX Apr $320 puts (or a 5% OTM 1‑month SPX put sized to match delta) to protect against a >7% one-day gap.
• Monitor three triggers over next 30 days before scaling: (1) IV spread (IV - realized) > +8ppt — continue selling premium; (2) major defense-budget or contract announcements — tighten stops; (3) flow/volume skew spike (>25% increase) — reduce size by 50%.